title: The role of interoception and alliesthesia in addiction.
abstract: This review presents a novel conceptualization of addiction, integrating the concepts of interoception (i.e., the CNS representation of visceral feelings) and alliesthesia (i.e., that rewarding properties of stimuli are dependent on the internal state of the individual) with existing theories. It is argued that the body state, as defined by the integration of interoceptive information, is a crucial arbiter of the risk for initiation of and transition to compulsive use of addictive compounds. Overall, individuals at risk for drug dependence are characterized by an altered internal bodily state that leads to a change in hedonic and incentive motivational properties of addictive drugs. Specifically, drug dependent individuals experience alliesthesia of interoceptive processing, leading to increased incentive motivational properties of the drug over time and thereby increasing the probability of subsequent use. This extension of previous theories of addiction to include interoception and alliesthesia is based upon a clearly delineated set of neural substrates mediating interoception, key elements of which also recently have been implicated in drug addiction. The model thereby provides new potential targets for interventions that are aimed at changing the internal state that puts the individual at risk for continued substance use.
authors.affiliation: Department of Psychiatry, University of California, San Diego, CA 92037, USA. mpaulus@ucsd.edu
authors.forename: Martin P
authors.initials: MP
authors.lastname: Paulus
authors.forename: Susan F
authors.initials: SF
authors.lastname: Tapert
authors.forename: Gery
authors.initials: G
authors.lastname: Schulteis
mesh_terms: D000818:Animals; D002490:Central Nervous System / Q000503:physiopathology*; D004644:Emotions; D006801:Humans; D008954:Models, Biological; D009042:Motivation; D010465:Perception / Q000502:physiology*; D057181:Pleasure; D012201:Reward; D012677:Sensation / Q000502:physiology; D019966:Substance-Related Disorders / Q000503:physiopathology* / Q000523:psychology
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
references.pmid: 18640920
references.citation: Annu Rev Neurosci. 2000;23:473-500
references.pmid: 10845072
references.citation: J Neurosci. 2005 Dec 14;25(50):11757-67
references.pmid: 16354934
references.citation: J Comp Neurol. 1982 Nov 20;212(1):38-52
references.pmid: 7174907
references.citation: Science. 1978 Jul 21;201(4352):262-4
references.pmid: 566469
references.citation: Nat Neurosci. 2005 Nov;8(11):1481-9
references.pmid: 16251991
references.citation: Nat Neurosci. 2008 Apr;11(4):389-97
references.pmid: 18368045
references.citation: Alcohol Clin Exp Res. 2008 Jun;32(6):1096-104
references.pmid: 18445111
references.citation: Annu Rev Psychol. 2008;59:29-53
references.pmid: 18154498
references.citation: Psychopharmacology (Berl). 2005 Dec;183(2):171-80
references.pmid: 16163517
references.citation: Science. 2007 Oct 26;318(5850):655-8
references.pmid: 17962567
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3125-35
references.pmid: 18640910
references.citation: Neurobiol Learn Mem. 1997 Jan;67(1):57-63
references.pmid: 9013501
references.citation: Brain Res Brain Res Rev. 2001 Oct;36(2-3):129-38
references.pmid: 11690609
references.citation: Nature. 2003 Jul 17;424(6946):316-20
references.pmid: 12867983
references.citation: Nature. 1999 Apr 15;398(6728):567-70
references.pmid: 10217139
references.citation: Dialogues Clin Neurosci. 2007;9(4):379-87
references.pmid: 18286798
references.citation: BMC Psychiatry. 2002 May 29;2:7
references.pmid: 12036434
references.citation: J Comp Neurol. 2005 Sep 19;490(2):101-18
references.pmid: 16052493
references.citation: Nat Neurosci. 2004 Feb;7(2):189-95
references.pmid: 14730305
references.citation: Neuron. 2009 Feb 12;61(3):481-90
references.pmid: 19217383
references.citation: J Abnorm Psychol. 2008 May;117(2):467-72
references.pmid: 18489224
references.citation: Cereb Cortex. 2000 Mar;10(3):206-19
references.pmid: 10731217
references.citation: Anat Rec A Discov Mol Cell Evol Biol. 2004 Nov;281(1):1212-25
references.pmid: 15470678
references.citation: Science. 2007 Jan 26;315(5811):531-4
references.pmid: 17255515
references.citation: Neuron. 2007 Apr 19;54(2):183-6
references.pmid: 17442239
references.citation: Science. 1971 Sep 17;173(4002):1103-7
references.pmid: 5098954
references.citation: Neuron. 2008 Jul 10;59(1):11-34
references.pmid: 18614026
references.citation: Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):377-93
references.pmid: 17169534
references.citation: Biol Psychiatry. 2006 Aug 15;60(4):383-7
references.pmid: 16780813
references.citation: Am Psychol. 1980 Aug;35(8):691-712
references.pmid: 7416563
references.citation: Nature. 2006 Feb 16;439(7078):865-70
references.pmid: 16482160
references.citation: Alcohol Res Health. 1999;23(3):215-24
references.pmid: 10890817
references.citation: Science. 2003 Oct 10;302(5643):290-2
references.pmid: 14551436
references.citation: Science. 1998 May 1;280(5364):747-9
references.pmid: 9563953
references.citation: Neurosci Lett. 2000 Jul 14;288(2):159-62
references.pmid: 10876085
references.citation: Addiction. 1996 Jul;91(7):921-49; discussion 951-65
references.pmid: 8688822
references.citation: Nat Rev Neurosci. 2005 Sep;6(9):691-702
references.pmid: 16136173
references.citation: J Comp Neurol. 2004 Jan 12;468(3):425-40
references.pmid: 14681935
references.citation: Psychol Rev. 2004 Jan;111(1):33-51
references.pmid: 14756584
references.citation: Brain Res. 2004 Mar 12;1000(1-2):78-84
references.pmid: 15053955
references.citation: Appetite. 2007 Mar;48(2):139-44
references.pmid: 17034902
references.citation: Nat Neurosci. 2005 Nov;8(11):1458-63
references.pmid: 16251988
references.citation: Alcohol Res Health. 1999;23(3):197-206
references.pmid: 10890815
references.citation: Ann N Y Acad Sci. 1998 May 1;840:33-44
references.pmid: 9629234
references.citation: Exp Clin Psychopharmacol. 2001 Feb;9(1):3-13
references.pmid: 11519632
references.citation: Nat Rev Neurosci. 2009 Jan;10(1):59-70
references.pmid: 19096369
references.citation: Physiol Behav. 1994 Jan;55(1):169-73
references.pmid: 8140163
references.citation: Lung. 2008;186 Suppl 1:S107-11
references.pmid: 17952695
references.citation: Neurotox Res. 2008 Oct;14(2-3):169-83
references.pmid: 19073424
references.citation: Trends Cogn Sci. 2004 Dec;8(12):539-46
references.pmid: 15556023
references.citation: Behav Brain Sci. 2008 Aug;31(4):415-37; discussion 437-87
references.pmid: 18662461
references.citation: Science. 2005 Feb 18;307(5712):1118-21
references.pmid: 15718473
references.citation: Trends Neurosci. 2009 Jan;32(1):56-67
references.pmid: 18986715
references.citation: Psychol Rev. 1974 Mar;81(2):119-45
references.pmid: 4817611
references.citation: Philos Trans R Soc Lond B Biol Sci. 2005 Apr 29;360(1456):797-814
references.pmid: 15937013
references.citation: Physiol Behav. 1999 Sep;67(3):409-15
references.pmid: 10497960
references.citation: Neuropharmacology. 2009;56 Suppl 1:48-62
references.pmid: 18722390
references.citation: Addiction. 2004 Dec;99(12):1542-7
references.pmid: 15585045
references.citation: Brain. 2001 Sep;124(Pt 9):1720-33
references.pmid: 11522575
references.citation: Neuroimage. 2002 Jun;16(2):331-48
references.pmid: 12030820
references.citation: Brain Res Brain Res Rev. 1996 Oct;22(3):229-44
references.pmid: 8957561
references.citation: Addiction. 2005 Mar;100(3):387-96
references.pmid: 15733252
references.citation: Addiction. 2004 Jun;99 Suppl 1:5-29
references.pmid: 15128378
references.citation: Science. 1997 Oct 3;278(5335):52-8
references.pmid: 9311926
references.citation: Nebr Symp Motiv. 1986;34:257-323
references.pmid: 3627296
references.citation: Am J Psychiatry. 2005 Aug;162(8):1403-13
references.pmid: 16055761
references.citation: Recent Dev Alcohol. 1998;14:177-95
references.pmid: 9751946